CSI Market
Sign In | Register

Caris Life Sciences Inc (CAI) Annual Balance Sheets

Annual · GAAP · USD millions
Access CAI quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Caris Life Sciences Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent0.00
Restricted Cash and Cash Equivalents, Current0.00
Marketable Securities, Current SH2.30
Cash & Short-term Investments2.00
Accounts receivable112.14
Other Receivables0.00
Notes, Loans and Financing Receivable, Net, Current AC0.00
Derivatives, Collateral, Regulatory, Deferred0.00
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets861.42
Total loans net21.94
Total Current Assets997.80
Equipment/Property/Plant Net0.00
Goodwill net19.34
Intangible Assets0.00
Long-term investments0.00
Notes, Loans and Financing Receivable, Net, Noncurrent LO0.00
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent108.52
Cash Cash Equivalents And Restricted Cash Current797.80
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization63.17
Total Assets1,125.66
Liabilities
Accounts Payable, Current AC39.21
Accrued Liabilities, Current AC87.77
Long-term Debt, Current Maturities LO0.17
Other Liabilities, Current0.00
Taxes Payable0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities127.15
Long-term debt378.82
Total Long-term Debt378.82
Derivative Liability, Noncurrent DE0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Other liabilities, Noncurrent42.39
Deferred Income Tax Liabilities Net-
Total Liabilities548.36
Stockholders' Equity
Treasury Stock Common Value-16.90
Common Stock Value0.28
Additional Paid In Capital Common Stock3,141.72
Retained Earnings / Accumulated Deficit-2,548.74
Accumulated Other Comprehensive Income0.00
Other Equity0.94
Common Stockholder's Equity577.31
Preferred Stockholder's Equity0.00
Total Stockholder's Equity577.31
Liabilities & Stockholder's Equity1,125.66
4 historic quarters locked

Sign in to unlock the full Caris Life Sciences Inc balance sheet history.

Sign In Create Free Account

About Caris Life Sciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 3, 2026
  • Source: cai-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0002019410-26-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License